(Q41043544)

26 September 2017

1 reference

title

von Willebrand disease: pathogenesis, classification, and management (English)

1 reference

26 September 2017

Murray EW

1

1 reference

26 September 2017

Lillicrap D

series ordinal

2

1 reference

26 September 2017

publication date

1 April 1996

1 reference

Transfusion Medicine Reviews

26 September 2017

published in

1 reference

26 September 2017

volume

10

1 reference

26 September 2017

issue

2

1 reference

26 September 2017

page(s)

93-110

1 reference

Biosynthesis of von Willebrand protein by human megakaryocytes

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Nucleotide sequence of pre-pro-von Willebrand factor cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

cDNA sequences for human von Willebrand factor reveal five types of repeated domains and five possible protein sequence polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Amino acid sequence of human von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Substructure of human von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Domains involved in multimer assembly of von willebrand factor (vWF): multimerization is independent of dimerization.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Identification of disulfide-bridged substructures within human von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Induction of specific storage organelles by von Willebrand factor propolypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Composition of the von Willebrand factor storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Human von Willebrand factor: a multivalent protein composed of identical subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Differing polarity of the constitutive and regulated secretory pathways for von Willebrand factor in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE).

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric size

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Distribution of factor VIII mRNA and antigen in human liver and other tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Localization of binding sites within human von Willebrand factor for monomeric type III collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

von Willebrand factor and platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Structure of pre-pro-von Willebrand factor and its expression in heterologous cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Conserved Sex-chromosome-associated Nucleotide Sequences in Eukaryotes

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Family studies in von Willebrand's disease by analysis of restriction fragment length polymorphisms and an intragenic variable number tandem repeat (VNTR) sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Sublocalization of von Willebrand factor pseudogene to 22q11.22-q11.23 by in situ hybridization in a 46,X,t(X;22)(pter;q11.21) translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

An evaluation of the molecular clock hypothesis using mammalian DNA sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

The Factor VIII Abnormality in Severe von Willebrand's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Gene deletions correlate with the development of alloantibodies in von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Defects in type IIA von Willebrand disease: a cysteine 509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein Ib-IX

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Platelet aggregation induced by type IIb platelet von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Type IIB von Willebrand's disease presenting as thrombocytopenia during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Evidence for a von Willebrand factor defect in factor VIII binding in three members of a family previously misdiagnosed mild haemophilia A and haemophilia A carriers: consequences for therapy and genetic counselling

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Tetranucleotide repeat polymorphism in the vWF gene

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Characterisation of 98 alleles in 105 unrelated individuals in the F8VWF gene

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Dinucleotide repeat polymorphism in the promoter region of the human von Willebrand factor gene (vWF gene)

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Rapid neonatal diagnosis of von Willebrand's disease by use of the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

An infrequent DNA polymorphism associated with severe von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Significant hyponatremia following DDAVP administration in a healthy adult

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP).

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Biological effect of desmopressin in eight patients with type 2N ('Normandy') von Willebrand disease. Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Replacement Therapy with Virus-Inactivated Plasma Concentrates in von Willebrand Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Von Willebrand factor multimer patterns in von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC)

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Investigation of a kindred with a new autosomal dominantly inherited variant type von Willebrand's disease (possible type IID).

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

A variant of type II von Willebrand disease with an abnormal triplet structure and discordant effects of protease inhibitors on plasma and platelet von Willebrand factor structure

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Type II H von Willebrand disease: new structural abnormality of plasma and platelet von Willebrand factor in a patient with prolonged bleeding time and borderline levels of ristocetin cofactor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

A new variant of von willebrand disease (type II I) with a normal degree of proteolytic cleavage of von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Abnormal proteolytic degradation of von Willebrand factor after desmopressin infusion in a new subtype of von Willebrand disease (ID)

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Identification of a new nonsense mutation in the von Willebrand factor gene in patients with von Willebrand disease type III

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Substitution of cysteine for phenylalanine 751 in mature von Willebrand factor is a novel candidate mutation in a family with type IIA von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

An Arg545----Cys545 substitution mutation of the von Willebrand factor in type IIB von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Recurring mutations at CpG dinucleotides in the region of the von Willebrand factor gene encoding the glycoprotein Ib binding domain, in patients with type IIB von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

Identification of two point mutations in the von Willebrand factor gene of three families with the ‘Normandy’variant of von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the secon

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980086-1

7 January 2021

10.1016/S0887-7963(96)80086-1

Identifiers

DOI

1 reference

26 September 2017

1 reference